Niacin Reduces Monocyte Adhesion, Boosts Adiponectin
METHODS: We studied the variation of monocyte adhesion in patients with type 2 diabetes and low HDL-cholesterol, taking either extended release niacin (Niaspan(®), Abbott Laboratories) or controls not on niacin. Biochemical parameters including adiponectin, CAMs and fresh monocytes from whole blood for adhesion asssays, were studied at baseline and 12-weeks.
RESULTS: Niacin 1500mg daily raised HDL-cholesterol from 0.8mmol/l (95% CI: 0.7-0.9) to 0.9mmol/l (95% CI: 0.8-1.1), p=0.10, and significantly reduced PECAM-1 by 24.9% (95% CI: 10.9-39.0; p<0.05), increased adiponectin by 30.5% (95% CI: 14.1-47.0; p<0.05), with monocyte adhesion reduced by 9.2% (95%CI: 0.7-17.7; p<0.05) in endothelial cells treated in basal conditions, and 7.8% (95% CI: 3.1-12.5; p<0.05) after TNF-α stimulation.
CONCLUSIONS: Monocytes isolated from patients on niacin had reduced adhesion to endothelial cells. Our findings suggest niacin has broad range of effects apart from lipid-modification, and these could be important in cardiovascular risk reduction.
Tavintharan S, Woon K, Pek LT, Jauhar N, Dong X, Lim SC, Sum CF.
Niacin results in reduced monocyte adhesion in patients with type 2 diabetes mellitus.
Department of Medicine, Khoo Teck Puat Hospital, 90 Yishun Central, Singapore 768828, Singapore